Kent E Pinkerton Selected Research

Smoke

1/2022	Soluble epoxide hydrolase inhibitor can protect the femoral head against tobacco smoke exposure-induced osteonecrosis in spontaneously hypertensive rats.
1/2022	Effects of life-stage and passive tobacco smoke exposure on pulmonary innate immunity and influenza infection in mice.
1/2021	MARCKS cooperates with NKAP to activate NF-kB signaling in smoke-related lung cancer.
1/2020	Differential lung inflammation and injury with tobacco smoke exposure in Wistar Kyoto and spontaneously hypertensive rats.
1/2020	Long-Term Sequelae of Smoking and Cessation in Spontaneously Hypertensive Rats.
1/2018	Effects of aging and environmental tobacco smoke exposure on ocular and plasma circulatory microRNAs in the Rhesus macaque.
1/2018	Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice.
1/2018	Exposure to tobacco smoke increases bone loss in spontaneously hypertensive rats.
1/2017	Prenatal environmental tobacco smoke exposure increases allergic asthma risk with methylation changes in mice.
1/2017	Perinatal exposure to environmental tobacco smoke is associated with changes in DNA methylation that precede the adult onset of lung disease in a mouse model.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kent E Pinkerton Research Topics

Disease

34	Inflammation (Inflammations) 01/2022 - 10/2002
18	Asthma (Bronchial Asthma) 01/2022 - 08/2006
14	Chronic Obstructive Pulmonary Disease (COPD) 01/2020 - 05/2008
11	Pneumonia (Pneumonitis) 01/2020 - 08/2002
10	Infections 01/2022 - 03/2006
8	Neoplasms (Cancer) 01/2021 - 02/2002
6	Lung Injury 01/2022 - 01/2002
6	Lung Neoplasms (Lung Cancer) 01/2021 - 05/2004
5	Lung Diseases (Lung Disease) 01/2017 - 03/2003
5	Atherosclerosis 01/2013 - 11/2005
4	Airway Remodeling 01/2020 - 02/2004
4	Cardiovascular Diseases (Cardiovascular Disease) 11/2016 - 11/2007
4	Eosinophilia 01/2016 - 03/2003
3	Wounds and Injuries (Trauma) 05/2022 - 01/2011
3	Emphysema 01/2020 - 06/2009
3	Bronchitis 01/2020 - 10/2007
3	Fibrosis (Cirrhosis) 02/2016 - 02/2004
3	Hypersensitivity (Allergy) 01/2016 - 08/2003
3	Airway Obstruction (Choking) 05/2012 - 02/2004
3	Sudden Infant Death (SID) 06/2011 - 01/2009
3	Cough 02/2010 - 02/2004
3	Metaplasia 11/2009 - 10/2002
3	Hyperplasia 01/2007 - 02/2004
2	Respiratory Hypersensitivity 01/2018 - 01/2007
2	Neoplasm Metastasis (Metastasis) 01/2018 - 04/2004
2	Communicable Diseases (Infectious Diseases) 12/2017 - 08/2007
2	Disease Susceptibility (Diathesis) 01/2017 - 09/2010
2	Respiratory Tract Infections (Respiratory Tract Infection) 03/2016 - 09/2007
2	Laryngitis 01/2016 - 04/2009
2	Respiratory Tract Diseases (Respiratory Tract Disease) 02/2015 - 08/2013
2	Persistent Infection 05/2012 - 09/2004
2	Bronchiolitis 05/2012 - 01/2010
2	Hypercholesterolemia 11/2007 - 02/2002
2	Allergic Bronchopulmonary Aspergillosis 06/2005 - 03/2003
2	Aspergillosis 06/2005 - 03/2003
1	Human Influenza (Influenza) 01/2022
1	Osteonecrosis (Kienbock's Disease) 01/2022
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2021
1	Dyspnea (Shortness of Breath) 01/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2020
1	Chronic Cough 01/2020
1	Osteoporosis 01/2018
1	Macular Degeneration (Age-Related Maculopathy) 01/2018

Drug/Important Bio-Agent (IBA)

56	SmokeIBA 01/2022 - 01/2002
12	CytokinesIBA 09/2021 - 08/2002
11	Tobacco Smoke Pollution (Passive Smoking)IBA 01/2021 - 02/2002
11	AllergensIBA 01/2019 - 02/2004
9	Particulate MatterIBA 05/2022 - 02/2004
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2002
6	OzoneIBA 01/2020 - 01/2002
6	Air Pollutants (Pollutants, Air)IBA 01/2020 - 08/2002
5	Epoxide HydrolasesIBA 01/2022 - 02/2005
4	SootIBA 01/2022 - 01/2016
4	MucinsIBA 01/2022 - 01/2007
4	ChemokinesIBA 01/2018 - 01/2012
4	N-hydroxysuccinimidyl digoxigenin- 3- O- methylcarbonyl- epsilon- aminocaproateIBA 01/2016 - 08/2003
4	Apolipoproteins E (ApoE)IBA 01/2013 - 04/2009
3	OvalbuminIBA 01/2022 - 02/2004
3	LipidsIBA 01/2022 - 08/2002
3	Biological ProductsIBA 01/2020 - 04/2009
3	AntioxidantsIBA 01/2018 - 10/2002
3	IronIBA 01/2018 - 12/2008
3	Immunoglobulin E (IgE)IBA 01/2017 - 08/2003
3	AcidsIBA 01/2016 - 02/2005
3	Oxidants (Oxidizing Agents)IBA 01/2014 - 11/2007
3	Mitochondrial DNA (mtDNA)IBA 01/2013 - 02/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 04/2009
2	AerosolsIBA 01/2022 - 02/2004
2	Histamine (Histamine Dihydrochloride)FDA Link 09/2021 - 08/2003
2	Environmental Pollutants (Pollutants, Environmental)IBA 01/2021 - 10/2007
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2015
2	Heme Oxygenase-1IBA 01/2017 - 01/2015
2	Interleukin-6 (Interleukin 6)IBA 02/2016 - 08/2002
2	Pharmaceutical PreparationsIBA 04/2015 - 01/2012
2	Citric Acid (Citrate)FDA LinkGeneric 01/2014 - 02/2004
2	Free RadicalsIBA 01/2010 - 10/2002
2	CollagenIBA 04/2009 - 01/2007
2	Nicotine FDA Link 05/2008 - 10/2006
1	Acetates (Acetic Acid Esters)FDA Link 01/2022
1	Sulfates (Sulfates, Inorganic)IBA 01/2022
1	Dronabinol (THC)FDA LinkGeneric 01/2022
1	Urea (Carbamide)FDA LinkGeneric 01/2022
1	Phosphates (Orthophosphate)IBA 01/2022
1	CXC ChemokinesIBA 01/2022
1	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 01/2022
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2022
1	Vitamin E FDA LinkGeneric 01/2022
1	SilverIBA 10/2021
1	IonsIBA 09/2021
1	Heavy MetalsIBA 09/2021
1	peptide AIBA 01/2021
1	Myristoylated Alanine-Rich C Kinase SubstrateIBA 01/2021
1	NF-kappa B (NF-kB)IBA 01/2021
1	Nitrogen DioxideIBA 01/2020
1	EnzymesIBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	LipopolysaccharidesIBA 01/2018

Therapy/Procedure

5	Therapeutics 01/2018 - 10/2006